Zx Pharma is science driven and consumer centered.
Its mission is to oversee subsidiaries and affiliates that make better products - even better.
Zx Pharma is led by highly experienced R&D and commercial executives.
The company focuses on its overarching strategy to bring innovative products, though the development and commercialization phases,
to doctors and consumers.
The company is privately owned and headquartered in Boca Raton, Florida.
Bios of the CEO and the CFO
Syed M. Shah, Ph.D.
CEO and Chief Innovation Officer
Dr. Shah has over 20 years experience in Big Pharma R&D (Pfizer, Wyeth and Lederle
Labs) and 10 years in foods R&D (Beatrice Foods and UOP Inc.).
He is the co-inventor of 55 U.S. patents and played a leadership role
in the pharmaceutical science effort behind four pharmaceutical blockbusters
Tygacil®, and Protonix®)
and is a co- inventor of their respective patents.
Dr. Shah, who has a Ph.D. in Chemical Engineering,
is the recipient of several individual and team awards.
He has presented and published in several peer reviewed journals.
Previously, Dr. Shah attended the Illinois Institute of Technology, where he obtained a
B.S. in Biology, an M.S. degree in Microbiology and an M.S. in Chemical Engineering.
Chief Financial Officer
Ms. Hassan has had extensive work experience in blue chip financial and
pharmaceutical institutions (Wyeth, Merrill Lynch, Publicis Healthcare Group and Goldman Sachs).
Ms. Hassan holds a B.S. in Entrepreneurial Studies and an M.B.A. in Finance
and Pharmaceutical Management, both from Fairleigh Dickinson University in Madison, New Jersey.
Ms. Hassan is affiliated with several charities, including Community Hope in New Jersey and the Unicorn Children’s Foundation in Florida